摘要
In the article titled"In vivo detection of metabolic ^(2)H-incorporation upon ingestion of ^(2)H_(2)O"(DOI 10.1097/JBR.0000000000000121),[1]the information in the"Conflicts of Interest"section is incomplete.The complete and correct information about the Conflicts of Interest is as follows:PS and KDS are cofounders of Deep Breath Intelligence AG(Switzerland),which develops breath-based diagnostic tools.KDS is consultant for Deep Breath Intelligence AG(Switzerland).All the other authors declare no competing interests.The concept of monitoring metabolic ^(2)H-incorporation non-invasively and in vivo via SESI-HRMS has been incorporated as a patent with the title"Mass spectrometry Method and System"in the China Intellectual Property Office PCT/CN2022/075436,filed on February 8^(th),2022.
